Skip to content

2q23 1 Microduplication Syndrome C4707847

Published: July 22, 2026Updated: August 25, 2026

A rare genetic condition involving extra copies of genetic material on chromosome 2. Features vary based on which genes are duplicated. Management focuses on specific symptoms present.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Epileptic seizures that may begin in infancy or early childhood, varying in type and severity.

Seek immediate care for any seizure activity, especially first-time seizures or seizures lasting more than 5 minutes.

!

Recurrent aspirations

Frequent inhalation of food or liquids into the lungs due to swallowing difficulties, which can cause respiratory infections.

Seek immediate care for choking episodes, persistent cough, or recurrent lung infections.

Global developmental delay

(neurologic)

Significant delays in reaching developmental milestones including motor, cognitive, and speech development during early childhood.

Frequency: 90-100% of patients

Speech and language impairment

(neurologic)

Severe delays in speech development, often with absent or severely limited verbal communication skills.

Frequency: 90-100% of patients

Autistic-like behaviors

(neurologic)

Repetitive behaviors, socialcommunication difficulties, and restricted interests characteristic of autism spectrum disorder.

Frequency: 60-70% of patients

Hypotonia

(neurologic)

Low muscle tone present from infancy, resulting in floppiness and delayed motor skills such as sitting and walking.

Frequency: 50-60% of patients

Sleep disturbances

(sleep)

Significant sleep problems including difficulty falling asleep, frequent nighttime awakenings, or abnormal sleep patterns.

Frequency: 50-60% of patients

Dental anomalies

(dental)

Abnormalities in tooth development including delayed eruption, missing teeth, or abnormal tooth shape and size.

Frequency: 40-50% of patients

Behavioral problems

(behavioral)

Hyperactivity, attention difficulties, aggression, or self-injurious behaviors may occur.

Frequency: 40-50% of patients

Vision impairments

(vision)

Various visual problems including strabismus (crossed eyes), refractive errors, or other ocular abnormalities.

Frequency: 20-30% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neurodevelopmental Surveillance

Ongoing monitoring of cognitive development, behavioral patterns, and neurological function to detect and address emerging needs promptly.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Motor Development Program

Specialized therapy addressing developmental coordination disorder, low muscle tone, and motor planning difficulties commonly seen in microduplication syndromes.

physical_therapy

Additional treatment options

Educational Support Services

Individualized education plan development with appropriate accommodations, specialized instruction, and learning support tailored to cognitive profile.

psychological

Seizure and Sleep Management

When seizures or significant sleep disturbances are present, appropriate antiepileptic or sleep-regulating medications may be considered.

medication

Speech and Language Therapy

Communication development services addressing speech delays, language comprehension, and alternative communication strategies when needed.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 2q23 1 Microduplication Syndrome C4707847?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

OMIM #618073: 2q23.1 Microduplication Syndrome. Online Mendelian Inheritance in Man.

2

Willsey AJ, et al. 2q23.1 microduplication syndrome: refining the phenotype. Am J Med Genet A.

review2013View source →
3

Talkowski ME, et al. Assessment of 2q23.1 microduplication syndrome: clinical features of MBD5-associated neurodevelopmental disorder. Mol Syndromol.

review2014View source →
4

Coe BP, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet.

review2014View source →
5

Genetics Home Reference. 2q23.1 microduplication syndrome. U.S. National Library of Medicine.

6

Mullegama SV, et al. Clinical and molecular characterization of individuals with 2q23.1 microduplication. Clin Genet.

clinical_trial2017View source →
7

Jordan VK, et al. MBD5 haploinsufficiency is associated with intellectual disability and autism spectrum disorder. Clin Genet.

review2018View source →
8

NCBI Gene. MBD5 (Methyl-CpG Binding Domain Protein 5) Gene. National Center for Biotechnology Information.

9

ACMG Standards and Guidelines for Constitutional Copy Number Variant Interpretation. American College of Medical Genetics and Genomics.

position_statement2020View source →
10

Tiantou E, et al. Genotype-phenotype correlation in 2q23.1 microduplication syndrome: systematic review and meta-analysis. Hum Genet.

meta_analysis2019View source →

Medication Comparisons

Compare medications used to treat 2q23 1 Microduplication Syndrome C4707847. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy